Drug profile · INN
afamelanotide
SCENESSE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
afamelanotide (SCENESSE) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN afamelanotide
Brand SCENESSE
Route SUBCUTANEOUS
Formulation IMPLANT
ATC code D02BB02
Frequently asked questions
What is afamelanotide?
afamelanotide (SCENESSE) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for afamelanotide?
SCENESSE is a marketed brand name for afamelanotide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of afamelanotide?
afamelanotide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.